Researchers at Massachusetts General Hospital (MGH)—using a fluorescence-activated cell sorting technique—have isolated egg-producing stem cells from the ovaries of reproductive-age women and shown that these cells can produce what appear to be normal egg cells (oocytes).

Cancer detection technology developer Verisante has entered into an exclusive agreement with Clarion Medical Technologies to distribute the company's Verisante Aura optical system for skin lesion evaluation in Canada.

Using high-resolution fluorescent imaging, scientists at the Karlsruhe Institute of Technology (KIT) and Heidelberg University have observed cell membrane repair in real time in a living organism for the first time.

Researchers from the Massachusetts Institute of Technology (MIT) Research Laboratory of Electronics (RLE) have developed a fiber light source with varied brightness that could enable medical devices to be threaded into narrow openings to irradiate diseased tissue while leaving healthy tissue untouched.

Michelson Diagnostics has gained a $955k investment for its VivoSight optical coherence tomography (OCT) scanners for non-melanoma skin cancer.

BD Biosciences, part of Becton, Dickinson and Company, and Jamia Hamdard University have set up the BD FACS Academy to train young scientists and researchers on flow cytometry, a laser-based measure of physical and chemical characteristics of cells, cell subsets, DNA, surface antigens, and bacteria.

Medical device maker Boston Scientific and holmium laser technology developer Lumenis recently inked a five-year contract extending their existing commercial agreement.

David J. Cuccia, Ph.D, chief technology officer and CEO at Modulated Imaging, will receive the 2012 Dr. Horace Furumoto Innovations Professional Development Grant at the Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS), to take place April 20–22 in Kissimmee, FL.

Purdue University researchers have created a new imaging technology that reveals subtle changes in breast tissue, representing a way to determine a woman's risk of developing breast cancer and to study ways of preventing it.

Laser device and advanced imaging systems maker Hamilton Thorne (TSX-V: HTL) has expanded its distribution partnership with optics systems producer Leica Microsystems.

Researchers from the Shizuoka Cancer Center Research Institute in Japan have developed an automated, noninvasive melanoma screening system that may eliminate the need for a morphological examination and reduce needless surgery.

With all cancers—but particularly with esophageal cancers—early detection can mean the difference between effective treatment and devastation.

A nanowire-based endoscope system is enabling fluorescence study of biological processes within single living cells in high spatial and temporal resolution.

With conventional fluorescence, the signal from mutated DNA might be only a few tenths of a percent higher than the background noise.

Researchers' novel approaches to optics are facilitating better microscopy. From lenses without glass (including a broadband one for super-resolution imaging and a solid-state approach for imaging deep into tissue) to smartphone-based microspectroscopy, the innovations are pointing the way toward better and less costly healthcare.

Spatial light interference microscopy (SLIM), a label-free, automated technique that enables quantitative visualization of nanoscale structures, uses phase-contrast microscopy and holography to combine multiple light waves.

A 90-second, noninvasive test using the palm of a person's hand can yield a snapshot of carotenoid levels (an antioxidant that protects cells from damage caused by free radicals) and indicate overall nutritional health.

The ability to make cancerous tissue glow promises great advantages for tumor detection during fluoresence image-guided surgery.

Cell migration is critical to such biological functions as wound healing and cancer metastasis, which require that many cells move together.